Marker Therapeutics Stock Price on November 14, 2024
| MRKR Stock | USD 3.10 0.15 5.08% |
Below is the normalized historical share price chart for Marker Therapeutics extending back to March 06, 1998. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Marker Therapeutics stands at 3.10, as last reported on the 23rd of November, with the highest price reaching 3.23 and the lowest price hitting 2.91 during the day.
If you're considering investing in Marker Stock, it is important to understand the factors that can impact its price. Marker Therapeutics has Sharpe Ratio of -0.0032, which conveys that the firm had a -0.0032% return per unit of risk over the last 3 months. Marker Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Marker Therapeutics' Mean Deviation of 5.13, standard deviation of 7.16, and Risk Adjusted Performance of 0.0087 to check out the risk estimate we provide.
At this time, Marker Therapeutics' Common Stock Shares Outstanding is relatively stable compared to the past year. As of 11/23/2024, Other Stockholder Equity is likely to grow to about 472.8 M, while Total Stockholder Equity is likely to drop slightly above 7.1 M. . At this time, Marker Therapeutics' Price Book Value Ratio is relatively stable compared to the past year. As of 11/23/2024, Price Earnings To Growth Ratio is likely to grow to 0.08, while Price Earnings Ratio is likely to drop (3.62). Marker Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 25th of March 2014 | 200 Day MA 3.9842 | 50 Day MA 3.3062 | Beta 1.492 |
Marker |
Sharpe Ratio = -0.0032
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | MRKR |
Estimated Market Risk
| 7.22 actual daily | 64 64% of assets are less volatile |
Expected Return
| -0.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Marker Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Marker Therapeutics by adding Marker Therapeutics to a well-diversified portfolio.
Price Book 3.7133 | Enterprise Value Ebitda (0.22) | Price Sales 7.4214 | Shares Float 6.8 M | Wall Street Target Price 19 |
Marker Therapeutics Main Headline on 14th of November 2024
Marker Therapeutics Reports Third Quarter 2024 Financial Res... by globenewswire.com
Marker Therapeutics to receive two grants from NIH Small Business Innovation Research program to support clinical investigation of MT-601 in...
Marker Therapeutics Valuation on November 14, 2024
It is possible to determine the worth of Marker Therapeutics on a given historical date. On November 14, 2024 Marker was worth 3.6 at the beginning of the trading date compared to the closed value of 3.5. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Marker Therapeutics stock. Still, in general, we apply an absolute valuation method to find Marker Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Marker Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Marker Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 3.81 | 3.90 | 3.60 | 3.64 | 23,679 | |
11/14/2024 | 3.60 | 3.85 | 3.50 | 3.50 | 11,014 |
| 3.44 | 3.44 | 3.03 | 3.07 | 43,941 |
| Backtest Marker Therapeutics | | | Marker Therapeutics History | | | Marker Therapeutics Valuation | Previous | Next |
Marker Therapeutics Trading Date Momentum on November 14, 2024
| On November 15 2024 Marker Therapeutics was traded for 3.07 at the closing time. The top price for the day was 3.44 and the lowest listed price was 3.03 . The trading volume for the day was 43.9 K. The trading history from November 15, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 12.29% . The trading delta at closing time against the current closing price is 15.43% . |
Marker Therapeutics Fundamentals Correlations and Trends
By evaluating Marker Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Marker Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Marker financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Marker Therapeutics Stock history
Marker Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Marker is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Marker Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Marker Therapeutics stock prices may prove useful in developing a viable investing in Marker Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 8.8 M | 9.2 M | |
| Net Loss | -37.7 M | -39.6 M |
Marker Therapeutics Quarterly Net Working Capital |
|
Marker Therapeutics Stock Technical Analysis
Marker Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Marker Therapeutics Period Price Range
Low | November 23, 2024
| High |
0.00 | 0.00 |
Marker Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Marker Therapeutics November 23, 2024 Market Strength
Market strength indicators help investors to evaluate how Marker Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Marker Therapeutics shares will generate the highest return on investment. By undertsting and applying Marker Therapeutics stock market strength indicators, traders can identify Marker Therapeutics entry and exit signals to maximize returns
Marker Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Marker Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Marker Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Marker to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0087 | |||
| Jensen Alpha | (0.29) | |||
| Total Risk Alpha | (1.14) | |||
| Treynor Ratio | (0.01) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Marker Stock Analysis
When running Marker Therapeutics' price analysis, check to measure Marker Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Marker Therapeutics is operating at the current time. Most of Marker Therapeutics' value examination focuses on studying past and present price action to predict the probability of Marker Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Marker Therapeutics' price. Additionally, you may evaluate how the addition of Marker Therapeutics to your portfolios can decrease your overall portfolio volatility.